Intervacc is trading at €0.07, down 14.9%, after a sharp decline during the September 2, 2026 session; the cause remains unclear.

  • DNB Carnegie’s September 1 Micro Cap Day flash comment is identified as recent news flow, but no company-specific negative catalyst has been reported or directly linked to the decline.
  • Biotechnology sector sentiment was positive, while broader U.S. markets were essentially flat; re-check for delayed company disclosures.